HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement Effects of Myelophil on Symptoms of Chronic Fatigue Syndrome in a Reserpine-Induced Mouse Model.

Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is associated with various symptoms, such as depression, pain, and fatigue. To date, the pathological mechanisms and therapeutics remain uncertain. The purpose of this study was to investigate the effect of myelophil (MYP), composed of Astragali Radix and Salviaemiltiorrhizae Radix, on depression, pain, and fatigue behaviors and its underlying mechanisms. Reserpine (2 mg/kg for 10 days, intraperitoneally) induced depression, pain, and fatigue behaviors in mice. MYP treatment (100 mg/kg for 10 days, intragastrically) significantly improved depression behaviors, mechanical and thermal hypersensitivity, and fatigue behavior. MYP treatment regulated the expression of c-Fos, 5-HT1A/B receptors, and transforming growth factor β (TGF-β) in the brain, especially in the motor cortex, hippocampus, and nucleus of the solitary tract. MYP treatment decreased ionized calcium binding adapter molecule 1 (Iba1) expression in the hippocampus and increased tyrosine hydroxylase (TH) expression and the levels of dopamine and serotonin in the striatum. MYP treatment altered inflammatory and anti-oxidative-related mRNA expression in the spleen and liver. In conclusion, MYP was effective in recovering major symptoms of ME/CFS and was associated with the regulation of dopaminergic and serotonergic pathways and TGF-β expression in the brain, as well as anti-inflammatory and anti-oxidant mechanisms in internal organs.
AuthorsJi-Hye Song, Seul-Ki Won, Geun-Hyang Eom, Da-Som Lee, Byung-Jin Park, Jin-Seok Lee, Chang-Gue Son, Ji-Yeun Park
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 22 Issue 19 (Sep 22 2021) ISSN: 1422-0067 [Electronic] Switzerland
PMID34638540 (Publication Type: Journal Article)
Chemical References
  • Aif1 protein, mouse
  • Anti-Inflammatory Agents
  • Antioxidants
  • Calcium-Binding Proteins
  • Drugs, Chinese Herbal
  • Microfilament Proteins
  • Myelophil
  • Proto-Oncogene Proteins c-fos
  • Reactive Oxygen Species
  • Receptor, Serotonin, 5-HT1B
  • Tgfb1 protein, mouse
  • Transforming Growth Factor beta1
  • Receptor, Serotonin, 5-HT1A
  • Serotonin
  • Reserpine
  • Tyrosine 3-Monooxygenase
  • Dopamine
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Antioxidants (pharmacology)
  • Behavior, Animal (drug effects)
  • Calcium-Binding Proteins (biosynthesis)
  • Corpus Striatum (metabolism)
  • Disease Models, Animal
  • Dopamine (analysis)
  • Drugs, Chinese Herbal (pharmacology)
  • Fatigue Syndrome, Chronic (drug therapy)
  • Hippocampus (metabolism)
  • Inflammation (drug therapy)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microfilament Proteins (biosynthesis)
  • Proto-Oncogene Proteins c-fos (metabolism)
  • Reactive Oxygen Species (metabolism)
  • Receptor, Serotonin, 5-HT1A (metabolism)
  • Receptor, Serotonin, 5-HT1B (metabolism)
  • Reserpine (adverse effects)
  • Serotonin (analysis)
  • Transforming Growth Factor beta1 (metabolism)
  • Tyrosine 3-Monooxygenase (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: